AF
PTCT icon

Allworth Financial’s PTC Therapeutics PTCT Stock Holding History

Allworth Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$46.2K Buy
678
+44
+7% +$3.12K ﹤0.01% 2379
2025
Q4 		$48.2K Buy
634
+247
+64% +$18K ﹤0.01% 2225
2025
Q3 		$23.8K Buy
387
+73
+23% +$3.8K ﹤0.01% 2592
2025
Q2 		$15.3K Buy
314
+245
+355% +$11.6K ﹤0.01% 2679
2025
Q1 		$3.42K Hold
69
– – ﹤0.01% 2970
2024
Q4 		$3.11K Hold
69
– – ﹤0.01% 2976
2024
Q3 		$2.56K Sell
69
-21
-23% -$703 ﹤0.01% 2855
2024
Q2 		$2.94K Hold
90
– – ﹤0.01% 2756
2024
Q1 		$2.62K Hold
90
– – ﹤0.01% 2711
2023
Q4 		$2.48K Buy
+90
New +$2.06K ﹤0.01% 2583
2023
Q3 		– Sell
-28
Closed -$1.14K – 3529
2023
Q2 		$1.14K Sell
28
-20
-42% -$979 ﹤0.01% 2692
2023
Q1 		$2.33K Buy
48
+20
+71% +$914 ﹤0.01% 2349
2022
Q4 		$1.07K Sell
28
-1
-3% -$42 ﹤0.01% 2449
2022
Q3 		$1K Buy
+29
New +$1.42K ﹤0.01% 2471
2022
Q1 		– Sell
-9
Closed – – 2322
2021
Q4 		$0 Sell
9
-273
-97% -$10.4K ﹤0.01% 2083
2021
Q3 		$10K Buy
+282
New +$11.6K ﹤0.01% 1343
2016
Q4 		– Sell
-900
Closed -$13K – 723
2016
Q3 		$13K Hold
900
– – ﹤0.01% 384
2016
Q2 		$6K Buy
+900
New +$6.6K ﹤0.01% 437

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Allworth Financial's PTCT Position: Q1 2026 in Review

Allworth Financial increased its PTC Therapeutics (PTCT) stake by 6.9% in Q1 2026, buying an estimated $3.12K and bringing the position to 678 shares worth $46.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2379.

Allworth Financial first reported a position in PTCT in Q2 2016 and has held it in 18 quarters since. The position peaked at $48.2K in Q4 2025. 349 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • Allworth Financial held 678 shares of PTC Therapeutics worth $46.2K as of Q1 2026.
  • Allworth Financial bought 44 PTC Therapeutics shares in Q1 2026, an estimated $3.12K.
  • PTC Therapeutics made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #2379 holding.
  • Allworth Financial first reported a position in PTC Therapeutics in Q2 2016 and has held it in 18 quarters since.
  • Allworth Financial's PTC Therapeutics position peaked at $48.2K in Q4 2025.
  • 349 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.